Rare diseases
Investigational molecules
Locations
Study on the Safety of Radiation and Nivolumab for Patients with Esophageal Cancer
NorwayStudy of Baricitinib in Children Aged 1 to 17 Hospitalized with COVID-19
BelgiumStudy of Vusolimogene Oderparepvec and Nivolumab for Patients with Solid Tumors
FranceStudy on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis
AustriaStudy on the Effects of Capecitabine and Oxaliplatin in Patients with Locally Advanced Colon Cancer
DenmarkStudy of MaaT013 (Fecal Transplantation) Combined with Ipilimumab and Nivolumab in Patients with Previously Untreated Melanoma
FranceStudy Comparing Avelumab and Standard Chemotherapy for Patients with Metastatic Colorectal Cancer with Microsatellite Instability
FranceStudy of Avutometinib and Defactinib for Patients with Recurrent Low-Grade Serous Ovarian Cancer
BelgiumStudy of Nivolumab for Patients with Esophageal Cancer Undergoing Active Surveillance After Chemoradiation
The NetherlandsStudy on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer
ItalyStudy on Lidocaine and Sodium Chloride for Patients Undergoing Liver Tumor Surgery
SwedenStudy of Drug Combination Treatment (Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan) Guided by Liquid Biopsy Testing in Patients with Stage III and High-Risk Stage II Colon Cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
